Companies›Industrials›Capital Goods›Industrial Products

Mitsu Chem Plast Limited

Capital Goods › Industrial Products
₹218.30
at close · 28 Oct 2026
▲ 2.30 (+1.06%)

Latest filings

Next results: Sat, 31 Oct · Financial Results
  1. Q2 and H1 FY27 earnings call scheduled for November 3 · Board & Shareholder Meetings
  2. Board to approve September 2026 quarterly and half-year results · Results
  3. Secretarial auditor resigns with immediate effect · Management Changes
All filings ↓
Ask Nexa about Mitsu Chem Plast Limited

Snapshot

What the business is, and whether it's a good one at a fair price.

AI · written from filings

Manufactures plastic products through blow molding and injection molding at four plants in Maharashtra, selling primarily to pharmaceutical, healthcare, agrochemical and FMCG customers in India and 17+ export countries. The core business is rigid plastic packaging containers (around 84% of revenue), used for storage and transport of liquids and chemicals. A second stream is Furnastra, a healthcare furniture brand (around 16% of revenue) sold in domestic and export markets, which carries a 15%+ EBITDA margin compared to lower margins on commodity containers. The company is adding a new Intermediate Bulk Container (IBC) vertical at Khalapur, slated to commission in Q2 FY27, and is commissioning an automated Unit 4 at Tarapur. Raw materials (notably HDPE polymer) make up about 59.7% of revenue and are the dominant cost line, with management noting HDPE prices running 30-40% above pre-war levels.

Revenue mix · reported segments
Packaging containers (rigid plastic drums, jerry cans, bottles)84.0%
Furnastra healthcare furniture16.0%
Operating scale
Installed capacity
32,450+ MT per annumFY26 (after June 2026 expansion)
Manufacturing plants
4 in MaharashtraFY26
Molding machines
51+ blow molding and 20+ injection molding machinesQ3 FY26
Volume
~21,000 tons in FY26; target ~27,000 tons in FY27FY26 / FY27 guidance
Capacity utilization
64%FY26
Export footprint
17+ countries across pharma, healthcare, chemical, FMCGFY26
Who pays it
Pharmaceutical, healthcare, agrochemical and FMCG companies; ~80% of business from 30-35 customers; exports to 17+ countries including Europe, Canada and Gulf.
Biggest cost
Raw materials (HDPE polymer and other plastics) at 59.7% of revenue.
Kind of business
Small-cap, asset-heavy plastics manufacturer with integrated blow and injection molding, dependent on polymer price cycles and order-book visibility of under one month.
Where it sits
BSE-listed plastic packaging manufacturer serving pharma, healthcare, agrochemical and FMCG end-markets in India and exports; currently around ₹350 crore revenue with stated aspiration to reach ₹1,000 crore by FY28.
Market Cap
₹296 Cr
P / E (TTM)
12.9×
EV / EBITDA
7.8×
Div Yield
0.09%
Growth
14.4%▲
Revenue 5y CAGR
PAT +10.0% · EBITDA +7.9%
Quality
20.2%▲
ROCE (5y median)
ROE 13.9% (5y median) · margin 10.1%
Leverage
0.57·
Debt / Equity · moderate
Net debt ₹64 Cr
Revenue FY21→FY26
2.0×▲
Margin −1.0 pts
₹178 Cr → ₹350 Cr
Cash conversion
1.59×▲
Operating cash ÷ profit · 5 yrs
₹87 Cr on ₹55 Cr
Moves on a normal day
1.67%·
Median daily move
Last 267 sessions · the yardstick for filing-day moves
Where it sits among 72 Packaging peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#23/64
P/B#47/61
ROCE#14/68
ROE#13/61
Debt / Equity#36/61
EBITDA margin#19/62
Revenue growth#34/61
Profit growth#8/60

Scorecard

Measured from the filed financials, judged against its Packaging peers · as of FY26 — not investment advice

Strengths
Revenue compounding 14% a year over 5 years
Returns on capital 20.2% (5-year median)
#14 of 68 in Packaging on the latest reported figures · down from 25.8% in FY21
Over 5 years it reported ₹55 Cr of profit and ₹87 Cr of operating cash — 1.59×
Profit is converting into cash
Concerns
Nothing flagged in the filed numbers.

Charts

How has the market priced it — with filings on the timeline?

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from Mitsu Chem Plast Limited's filed financials and exchange disclosures

What does Mitsu Chem Plast Limited do?

Mitsu Chem Plast Limited is a Industrial Products company listed on BSE.

Is Mitsu Chem Plast Limited profitable?

Yes. Over the trailing twelve months Mitsu Chem Plast Limited reported a net profit of ₹23 Cr on revenue of ₹360 Cr.

Does Mitsu Chem Plast Limited pay a dividend?

Yes. The dividend yield is 0.09% at the current price. It paid out 2% of its profit as dividend in FY26.

Is Mitsu Chem Plast Limited debt-free?

No. It reported borrowings of ₹64 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹64 Cr after cash. Debt stands at 0.57× equity. That is higher than 58% of its 61 Packaging peers.

Is Mitsu Chem Plast Limited expensive compared with its peers?

On trailing P/E, Mitsu Chem Plast Limited ranks 23 of 64 in Packaging — cheaper than 65% of them, against an industry median of 16.2×. This is a position, not a valuation judgement.

How much does the Mitsu Chem Plast Limited share price move in a day?

On a typical session Mitsu Chem Plast Limited moves 1.67% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.

When are Mitsu Chem Plast Limited's next results?

Financial Results on Sat, 31 Oct. MarketPing alerts you on WhatsApp the moment the filing lands.

Where can I track Mitsu Chem Plast Limited's announcements?

Every NSE and BSE filing by Mitsu Chem Plast Limited appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.